β-Arrestins modulate Adenovirus-vector-induced innate immune responses: Differential regulation by β-arrestin-1 and β-arrestin-2

Virus Research

Volumn 147, Issue 1, 2010, Pages 123-134

  Seregin, Sergey S ^a   Appledorn, Daniel M ^a   Patial, Sonika ^c   Bujold, M ^a   Nance, W ^a   Godbehere, S ^a   Parameswaran, Narayanan ^c   Amalfitano, Andrea ^a,b  

^a Michigan State University ^*  (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Arrestin 1; Arrestin 2; Innate immunity; Liver; Recombinant Adenovirus

Indexed keywords

ADENOVIRUS VECTOR; BETA ARRESTIN 1; BETA ARRESTIN 2;

ADENOVIRUS 5; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; EMBRYO; GENE THERAPY; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOREGULATION; INFLAMMATION; INNATE IMMUNITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; SAFETY; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ADENOVIRUSES, HUMAN; ANIMALS; ARRESTINS; CYTOKINES; GENE EXPRESSION REGULATION; GENETIC VECTORS; IMMUNOMODULATION; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL;

ADENOVIRIDAE; MIRIDAE;

EID: 71149116376     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2009.10.023     Document Type: Article

References (38)

1. Amalfitano A., Hauser M.A., Hu H., Serra D., Begy C.R., and Chamberlain J.S. Production and characterization of improved adenovirus vectors with the E1, E2b, and E3 genes deleted. J. Virol. 72 2 (1998) 926-933
2. Appledorn D.M., Kiang A., McBride A., Jiang H., Seregin S., Scott J.M., Stringer R., Kousa Y., Hoban M., Frank M.M., and Amalfitano A. Wild-type adenoviruses from groups A-F evoke unique innate immune responses, of which HAd3 and SAd23 are partially complement dependent. Gene Ther. 15 12 (2008) 885-901
3. Appledorn D.M., McBride A., Seregin S., Scott J.M., Schuldt N., Kiang A., Godbehere S., and Amalfitano A. Complex interactions with several arms of the complement system dictate innate and humoral immunity to adenoviral vectors. Gene Ther. 15 24 (2008) 1606-1617
4. Appledorn D.M., Patial S., Godbehere S., Parameswaran N., and Amalfitano A. TRIF, and TRIF-interacting TLRs differentially modulate several adenovirus vector-induced immune responses. J. Innate Immunity 1 4 (2009) 376-388
5. Appledorn D.M., Patial S., McBride A., Godbehere S., Van Rooijen N., Parameswaran N., and Amalfitano A. Adenovirus vector-induced innate inflammatory mediators, MAPK signaling, as well as adaptive immune responses are dependent upon both TLR2 and TLR9 in vivo. J. Immunol. 181 3 (2008) 2134-2144
6. Barrington R., Zhang M., Fischer M., and Carroll M.C. The role of complement in inflammation and adaptive immunity. Immunol. Rev. 180 (2001) 5-15
7. Cerullo V., Seiler M.P., Mane V., Brunetti-Pierri N., Clarke C., Bertin T.K., Rodgers J.R., and Lee B. Toll-like receptor 9 triggers an innate immune response to helper-dependent adenoviral vectors. Mol. Ther. 15 2 (2007) 378-385
8. Cichon G., Boeckh-Herwig S., Schmidt H.H., Wehnes E., Muller T., Pring-Akerblom P., and Burger R. Complement activation by recombinant adenoviruses. Gene Ther. 8 23 (2001) 1794-1800
9. Cotter M.J., Zaiss A.K., and Muruve D.A. Neutrophils interact with adenovirus vectors via Fc receptors and complement receptor 1. J. Virol. 79 23 (2005) 14622-14631
10. Croyle M.A., Le H.T., Linse K.D., Cerullo V., Toietta G., Beaudet A., and Pastore L. PEGylated helper-dependent adenoviral vectors: highly efficient vectors with an enhanced safety profile. Gene Ther. 12 7 (2005) 579-587
11. DeWire S.M., Ahn S., Lefkowitz R.J., and Shenoy S.K. Beta-arrestins and cell signaling. Annu. Rev. Physiol. 69 (2007) 483-510
12. Di Paolo N.C., Miao E.A., Iwakura Y., Murali-Krishna K., Aderem A., Flavell R.A., Papayannopoulou T., and Shayakhmetov D.M. Virus binding to a plasma membrane receptor triggers interleukin-1 alpha-mediated proinflammatory macrophage response in vivo. Immunity 31 1 (2009) 110-121
13. Everett R.S., Hodges B.L., Ding E.Y., Xu F., Serra D., and Amalfitano A. Liver toxicities typically induced by first-generation adenoviral vectors can be reduced by use of E1, E2b-deleted adenoviral vectors. Hum. Gene Ther. 14 18 (2003) 1715-1726
14. Fan H., Luttrell L.M., Tempel G.E., Senn J.J., Halushka P.V., and Cook J.A. Beta-arrestins 1 and 2 differentially regulate LPS-induced signaling and pro-inflammatory gene expression. Mol. Immunol. 44 12 (2007) 3092-3099
15. Gao H., Sun Y., Wu Y., Luan B., Wang Y., Qu B., and Pei G. Identification of beta-arrestin2 as a G protein-coupled receptor-stimulated regulator of NF-kappaB pathways. Mol. Cell 14 3 (2004) 303-317
16. Hartman Z.C., Appledorn D.M., and Amalfitano A. Adenovirus vector induced innate immune responses: impact upon efficacy and toxicity in gene therapy and vaccine applications. Virus Res. 132 1-2 (2008) 1-14
17. Hartman Z.C., Black E.P., and Amalfitano A. Adenoviral infection induces a multi-faceted innate cellular immune response that is mediated by the toll-like receptor pathway in A549 cells. Virology 358 2 (2007) 357-372
18. Hartman Z.C., Kiang A., Everett R.S., Serra D., Yang X.Y., Clay T.M., and Amalfitano A. Adenovirus infection triggers a rapid, MyD88-regulated transcriptome response critical to acute-phase and adaptive immune responses in vivo. J. Virol. 81 4 (2007) 1796-1812
19. Hodges B.L., Evans H.K., Everett R.S., Ding E.Y., Serra D., and Amalfitano A. Adenovirus vectors with the 100K gene deleted and their potential for multiple gene therapy applications. J. Virol. 75 13 (2001) 5913-5920
20. Hofstetter J.R., Zhang A., Mayeda A.R., Guscar T., Nurnberger Jr. J.I., and Lahiri D.K. Genomic DNA from mice: a comparison of recovery methods and tissue sources. Biochem. Mol. Med. 62 2 (1997) 197-202
21. Hu H., Serra D., and Amalfitano A. Persistence of an [E1-, polymerase-] adenovirus vector despite transduction of a neoantigen into immune-competent mice. Hum. Gene Ther. 10 3 (1999) 355-364
22. Jia Q., Zhou H.R., Shi Y., and Pestka J.J. Docosahexaenoic acid consumption inhibits deoxynivalenol-induced CREB/ATF1 activation and IL-6 gene transcription in mouse macrophages. J. Nutr. 136 2 (2006) 366-372
23. Kiang A., Hartman Z.C., Everett R.S., Serra D., Jiang H., Frank M.M., and Amalfitano A. Multiple innate inflammatory responses induced after systemic adenovirus vector delivery depend on a functional complement system. Mol. Ther. 14 4 (2006) 588-598
24. Kirschfink M. Controlling the complement system in inflammation. Immunopharmacology 38 1-2 (1997) 51-62
25. Liu Q., Zaiss A.K., Colarusso P., Patel K., Haljan G., Wickham T.J., and Muruve D.A. The role of capsid-endothelial interactions in the innate immune response to adenovirus vectors. Hum. Gene Ther. 14 7 (2003) 627-643
26. Loniewski K., Shi Y., Pestka J., and Parameswaran N. Toll-like receptors differentially regulate GPCR kinases and arrestins in primary macrophages. Mol. Immunol. 45 8 (2008) 2312-2322
27. Makrides S.C. Therapeutic inhibition of the complement system. Pharmacol. Rev. 50 1 (1998) 59-87
28. Muruve D.A., Petrilli V., Zaiss A.K., White L.R., Clark S.A., Ross P.J., Parks R.J., and Tschopp J. The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 452 7183 (2008) 103-107
29. Ng P., and Graham F.L. Construction of first-generation adenoviral vectors. Methods Mol. Med. 69 (2002) 389-414
30. Parameswaran N., Pao C.S., Leonhard K.S., Kang D.S., Kratz M., Ley S.C., and Benovic J.L. Arrestin-2 and G protein-coupled receptor kinase 5 interact with NFkappaB1 p105 and negatively regulate lipopolysaccharide-stimulated ERK1/2 activation in macrophages. J. Biol. Chem. 281 45 (2006) 34159-34170
31. Rajagopal K., Whalen E.J., Violin J.D., Stiber J.A., Rosenberg P.B., Premont R.T., Coffman T.M., Rockman H.A., and Lefkowitz R.J. Beta-arrestin2-mediated inotropic effects of the angiotensin II type 1A receptor in isolated cardiac myocytes. Proc. Natl. Acad. Sci. U. S. A. 103 44 (2006) 16284-16289
32. Schiedner G., Bloch W., Hertel S., Johnston M., Molojavyi A., Dries V., Varga G., Van Rooijen N., and Kochanek S. A hemodynamic response to intravenous adenovirus vector particles is caused by systemic Kupffer cell-mediated activation of endothelial cells. Hum. Gene Ther. 14 17 (2003) 1631-1641
33. Seregin S.S., Aldhamen Y.A., Appledorn D.M., Schuldt N.J., McBride A.J., Bujold M., Godbehere S.S., and Amalfitano A. CR1/2 is an important suppressor of Adenovirus-induced innate immune responses and is required for induction of neutralizing antibodies. Gene Ther. 16 10 (2009) 1245-1259
34. Seregin S.S., Appledorn D.M., McBride A.J., Schuldt N.J., Aldhamen Y.A., Voss T., Wei J., Bujold M., Nance W., Godbehere S., and Amalfitano A. Transient pretreatment with glucocorticoid ablates innate toxicity of systemically delivered adenoviral vectors without reducing efficacy. Mol. Ther. 17 4 (2009) 685-696
35. Smith J.G., and Nemerow G.R. Mechanism of adenovirus neutralization by Human alpha-defensins. Cell Host Microbe 3 1 (2008) 11-19
36. Song M.Y., Park S.K., Kim C.S., Yoo T.H., Kim B., Kim M.S., Kim Y.S., Kwag W.J., Lee B.K., and Baek K. Characterization of a novel anti-human TNF-alpha murine monoclonal antibody with high binding affinity and neutralizing activity. Exp. Mol. Med. 40 1 (2008) 35-42
37. Wang Y., Tang Y., Teng L., Wu Y., Zhao X., and Pei G. Association of beta-arrestin and TRAF6 negatively regulates Toll-like receptor-interleukin 1 receptor signaling. Nat. Immunol. 7 2 (2006) 139-147
38. Wolins N., Lozier J., Eggerman T.L., Jones E., Aguilar-Cordova E., and Vostal J.G. Intravenous administration of replication-incompetent adenovirus to rhesus monkeys induces thrombocytopenia by increasing in vivo platelet clearance. Br. J. Haematol. 123 5 (2003) 903-905